Scynexis verzeichnet drastische Verluste und UmsatzeinbrĂĽche ...
Critical Financial Report Looms
Market Reaction and Analyst Sentiment
Spero Therapeutics bereitet FDA-Zulassungsantrag fĂĽr tebipenem ...
Financial Position and Strategic Focus
Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL ...
Bioversys to Present at Stifel 2025 Annual Healthcare Conference ...
BioNTech’s Quarterly Results Reveal Challenges
Bioversys announces appointment of anti-infective expert ...
Europa Schluss: Indizes vor US-Zinsentscheid auf Rekordhöhen ...
Aktien Europa: Leichte Gewinne - Quartalsberichtssaison ...
AKTIE IM FOKUS: Optimistischere Jahresziele katapultieren ...
Pharmakonzern GSK hebt nach unerwartet starkem Quartal nochmals ...
TAGESVORSCHAU: Termine am 29. Oktober 2025
TAGESVORSCHAU: Termine am 29. Oktober 2025
Strategic Consolidation in mRNA Sector
GSK's Oncology Advance Poses a Direct Threat
ANALYSE-FLASH: JPMorgan belässt GSK auf Underweight - Ziel ...
GSK und US-Partner Alector stellen Tests an Demenzmittel ...
GSK stellt auf dem Gartner Supply Chain Planning Summit ...
GNW-News: Nilo Therapeutics startet mit einer Serie-A-Finanzierung ...
Trotz starker Quartalszahlen und neuer Medikamente sieht ...
Europa Schluss: EuroStoxx auf Rekordhoch - Pharmaaktien ...
Aktien Europa Schluss: EuroStoxx auf Rekordhoch - Pharmaaktien ...
Europa Schluss: Auf hohem Niveau risikoscheu - Blick geht ...
Der britische Pharmariese GSK vollzieht FĂĽhrungswechsel ...
Aktien Europa: Leichte Gewinne zum Wochenauftakt
Pharmakonzern GSK bekommt neuen Unternehmenschef
Adler Group announces the sale of the Berlin development ...
Adler Group gibt den Verkauf des Berliner Entwicklungsprojekts ...
Resolution Therapeutics appoints Lucy Singah as Chief Financial ...
Bioversys reports corporate highlights and key financials ...
GSK Aktie: Steigende Erwartungen. Blenrep: Internationale ...
Bioversys To announce its FIrst half 2025 financial results ...
GSK 3 Inhibitor Market Landscape Shows Promising Upswing ...
BioVersys receives EMA Orphan Designation for the combination ...
CureVac veröffentlicht Finanzergebnisse für das zweite ...
CureVac Announces Financial Results for the Second Quarter ...
Biontech und Curevac beenden Patentstreit
Biontech und Curevac beenden Patentstreit. Nun wurde ein ...
Global Biotechnology Market Outlook 2025: Driving Growth ...
Clarivate Identifies Eleven Potential Blockbuster and Transformative ...
2024 Access to Medicine Index zeigt dass Pharmaunternehmen ...
Department of Health - Abu Dhabi partners with GSK to Establish ...
L indice 2024 sur l accès aux médicaments révèle que ...
Nasal Polyposis Treatment Market to Reach US$ 6.8 Bn by ...
ABL Bio anuncia un acuerdo de licencia con GSK para la plataforma ...
Injectable Drug Delivery Market Worth $1139.4 billion | ...
Pharmaceutical Fine Chemicals Market worth USD 246.5 Billion ...
Regulatory T-cells Market to Observe Significant Growth ...
RNAi Therapeutics and Technology Market Worth USD 5.36 Billion ...
Global Healthcare E-commerce Market to Accrue $1038.17 Billion ...
Biopharma Leaders Unite to Shape the Future of Customer-Centric ...
Global AI Arms Race Accelerates with Cutting-Edge Tech and ...
Abzena Strengthens Board with Appointment of Biopharma Industry ...
Immunotherapy Drugs Market worth $580.6 billion by 2029 ...
Oncology Market Assessment: Strategic Insights for Investment ...
ABL Bio gibt Lizenzvertrag mit GSK ĂĽber Grabody-B-Plattform ...
Der Veeva European Commercial Summit versammelt fĂĽhrende ...
A Total of USD 12.7 Million Investment in New Diagnostics ...
ABL Bio Announces Grabody-B Brain Delivery Platform License ...
Veeva Pulse Shows Doctors Opening Up Two-Way Communications ...
Fortune veröffentlicht erstmals Liste der Europe's Most ...
Non-Insulin Therapies for Diabetes Market to Reach USD 58.6 ...
Veeva Pulse zeigt dass die Ă–ffnung der Zwei-Wege-Kommunikation ...
Abzena Announces Establishment of Scientific Advisory Board ...
$101M XPRIZE HEALTHSPAN AWARDS FIRST MILESTONE WINNERS DRIVING ...
Vaccine Adjuvants Market to Hit USD 0.96 Billion by 2029 ...
ABL Bio annonce la signature d'un accord de licence avec ...
Global Gastroparesis Treatment Market is Expected to Grow ...
High Potency Drug Market worth USD 379.20 Billion by 2031 ...
Pneumonia Vaccine Market Poised for Significant Expansion: ...
Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine ...
Vaccines Market Worth $94.9 billion | MarketsandMarkets™ ...
Ovarian Cancer Drugs Market Size expected to reach US$ 4.23 ...
Top Biopharma verpflichtet sich zu Veeva Vault CRM fĂĽr ...
Autoinjectors Market to Hit USD 3.02 Billion by 2030: Growth ...
Global Allergen Blocker Market is Projected to Reach Around ...
Beyond the Horizon: Innovative Drug Combinations Offer New ...
ABL Bio anuncia un acuerdo de licencia con GSK para la plataforma ...
O ĂŤndice de Acesso a Medicamentos de 2024 constata que ...
Aberta Consulta PĂşblica para inclusĂŁo de tratamento para ...
ABL Bio anuncia contrato de licença da plataforma de penetração ...
El ĂŤndice de Acceso a los Medicamentos de 2024 revela que ...
The Instant Group avanza en su expansiĂłn mundial con una ...
Clarivate Identifies Eleven Potential Blockbuster and Transformative ...
ABL Bio Announces Grabody-B Brain Delivery Platform License ...
A Total of USD 12.7 Million Investment in New Diagnostics ...
AKTIEN IM FOKUS: Pharmawerte unter Druck - Trump forderte ...
ANALYSE-FLASH: UBS belässt GSK auf Neutral - Ziel 1600 ...